Integral Health Asset Management LLC Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Integral Health Asset Management LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 40,000 shares of the medical equipment provider's stock, valued at approximately $20,878,000. Intuitive Surgical makes up approximately 1.8% of Integral Health Asset Management LLC's portfolio, making the stock its 15th biggest holding.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ISRG. Czech National Bank lifted its position in Intuitive Surgical by 6.9% in the fourth quarter. Czech National Bank now owns 77,227 shares of the medical equipment provider's stock valued at $40,309,000 after acquiring an additional 4,970 shares during the last quarter. Fiduciary Alliance LLC grew its position in shares of Intuitive Surgical by 33.7% during the fourth quarter. Fiduciary Alliance LLC now owns 12,497 shares of the medical equipment provider's stock worth $6,523,000 after acquiring an additional 3,151 shares during the last quarter. Brookstone Capital Management raised its position in Intuitive Surgical by 25.4% in the 4th quarter. Brookstone Capital Management now owns 18,102 shares of the medical equipment provider's stock valued at $9,448,000 after purchasing an additional 3,663 shares during the last quarter. Capital Investment Advisors LLC boosted its stake in Intuitive Surgical by 15.6% during the 4th quarter. Capital Investment Advisors LLC now owns 899 shares of the medical equipment provider's stock worth $469,000 after purchasing an additional 121 shares during the period. Finally, Kieckhefer Group LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth $5,632,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded down $5.66 during trading hours on Thursday, reaching $560.28. The company's stock had a trading volume of 1,793,655 shares, compared to its average volume of 1,637,751. The company's 50-day moving average is $502.26 and its two-hundred day moving average is $535.79. Intuitive Surgical, Inc. has a fifty-two week low of $386.00 and a fifty-two week high of $616.00. The stock has a market cap of $200.81 billion, a PE ratio of 87.41, a PEG ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period last year, the company posted $1.50 EPS. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ISRG has been the subject of several recent research reports. Citigroup increased their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research note on Friday, January 24th. Piper Sandler cut their price target on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Erste Group Bank cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Finally, CICC Research began coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They issued a "neutral" rating and a $550.00 target price for the company. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $598.95.

Insider Activity

In other news, EVP Brian Edward Miller sold 8,900 shares of the firm's stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now owns 5,758 shares in the company, valued at $2,793,033.06. This trade represents a 60.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Jamie Samath sold 188 shares of the company's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the transaction, the chief financial officer now owns 7,162 shares of the company's stock, valued at $4,060,424.28. The trade was a 2.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 32,680 shares of company stock worth $16,854,345 over the last three months. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.